LIGOCYTE PHARMACEUTICALS
LigoCyte is breaking new ground in the treatment of inflammatory and infectious disease. We have produced a number of novel drug compounds to modify immune responses by focusing on cell binding interactions and their role in the immune system. Immunomodulatory drugs represent one of the most exciting areas of pharmaceutical research today, addressing the disease process itself rather than simply treating the resulting symptoms. LigoCyte is advancing its proprietary products into human clinical testing, positioning the company for continued growth and success in the biotechnology industry.
LIGOCYTE PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Bozeman, Montana, United States
Country:
United States
Website Url:
http://www.ligocyte.com
Total Employee:
11+
Status:
Active
Contact:
406-585-2733
Total Funding:
43.56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Bodis DNS
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Current Employees Featured
Investors List
JAFCO
JAFCO investment in Series C - LigoCyte Pharmaceuticals
MedImmune Ventures
MedImmune Ventures investment in Series C - LigoCyte Pharmaceuticals
Athenian Venture Partners
Athenian Venture Partners investment in Series C - LigoCyte Pharmaceuticals
Novartis Venture Fund
Novartis Venture Fund investment in Series C - LigoCyte Pharmaceuticals
Forward Ventures
Forward Ventures investment in Series C - LigoCyte Pharmaceuticals
Eight Roads Ventures
Eight Roads Ventures investment in Venture Round - LigoCyte Pharmaceuticals
Official Site Inspections
http://www.ligocyte.com
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
